Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Utah Medical Products, Inc. before investing.

In this article, we go over a few key elements for understanding Utah Medical Products, Inc.’s stock price such as:

• Utah Medical Products, Inc.’s current stock price and volume
• Why Utah Medical Products, Inc.’s stock price changed recently
• Upgrades and downgrades for UTMD from analysts
• UTMD’s stock price momentum as measured by its relative strength

About Utah Medical Products, Inc. (UTMD)

Before we jump into Utah Medical Products, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women’s health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Want to learn more about Utah Medical Products, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Utah Medical Products, Inc..

Utah Medical Products, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Utah Medical Products, Inc.’s stock price was $70.520.

Utah Medical Products, Inc. is up 1.37% from its previous closing price of $69.570.

During the last market session, Utah Medical Products, Inc.’s stock traded between $69.410 and $70.760. Currently, there are approximately 3.19 million shares outstanding for Utah Medical Products, Inc..

Utah Medical Products, Inc.’s price-earnings (P/E) ratio is currently at 20.9, which is low compared to the Health Care Equipment & Supplies industry median of 31.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Utah Medical Products, Inc. Stock Price History

Utah Medical Products, Inc.’s (UTMD) price is currently up 2.23% so far this month.

During the month of July, Utah Medical Products, Inc.’s stock price has reached a high of $74.400 and a low of $63.785.

Over the last year, Utah Medical Products, Inc. has hit prices as high as $75.750 and as low as $53.660. Year to date, Utah Medical Products, Inc.’s stock is up 26.02%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Utah Medical Products, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were analysts who downgraded Utah Medical Products, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Utah Medical Products, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Utah Medical Products, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Utah Medical Products, Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Utah Medical Products, Inc. (UTMD) by visiting AAII Stock Evaluator.

Relative Price Strength of Utah Medical Products, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Utah Medical Products, Inc. has a weighted four-quarter relative price strength of 2.20%, which translates to a Momentum Score of 61 and is considered to be Strong.

Want to learn more about how Utah Medical Products, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Utah Medical Products, Inc. Stock Price: Bottom Line

As of July 31, 2026, Utah Medical Products, Inc.’s stock price is $70.520, which is up 1.37% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Utah Medical Products, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.